Taylor Wealth Management Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-15
Closed -$4K 160
2016
Q4
$4K Hold
15
﹤0.01% 149
2016
Q3
$5K Hold
15
﹤0.01% 134
2016
Q2
$4K Sell
15
-8
-35% -$2.11K ﹤0.01% 129
2016
Q1
$6K Hold
23
﹤0.01% 124
2015
Q4
$7K Hold
23
﹤0.01% 119
2015
Q3
$7K Hold
23
﹤0.01% 128
2015
Q2
$9K Hold
23
﹤0.01% 154
2015
Q1
$10K Buy
+23
New +$9.06K ﹤0.01% 140

Other funds holding BIIB

Taylor Wealth Management Partners's BIIB Position: Q1 2017 in Review

Taylor Wealth Management Partners sold out of Biogen (BIIB) in Q1 2017, closing a stake of 15 shares — an estimated $4K sold.

Taylor Wealth Management Partners first reported a position in BIIB in Q1 2015 and held it in 8 quarters. The position peaked at $10K in Q1 2015. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Taylor Wealth Management Partners reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • Taylor Wealth Management Partners sold 15 Biogen shares in Q1 2017, an estimated $4K.
  • Taylor Wealth Management Partners first reported a position in Biogen in Q1 2015 and held it in 8 quarters.
  • Taylor Wealth Management Partners's Biogen position peaked at $10K in Q1 2015.
  • 1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Taylor Wealth Management Partners's 13F filing for Q1 2017, filed 24 Apr 2017.